nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Parkinson's disease	0.585	1	CbGaD
Carfilzomib—PSMB10—head—Parkinson's disease	0.00599	0.0477	CbGeAlD
Carfilzomib—PSMB1—embryo—Parkinson's disease	0.00588	0.0468	CbGeAlD
Carfilzomib—PSMB2—embryo—Parkinson's disease	0.00574	0.0457	CbGeAlD
Carfilzomib—PSMB10—nervous system—Parkinson's disease	0.00568	0.0452	CbGeAlD
Carfilzomib—PSMB10—central nervous system—Parkinson's disease	0.00546	0.0435	CbGeAlD
Carfilzomib—PSMB10—cerebellum—Parkinson's disease	0.00534	0.0425	CbGeAlD
Carfilzomib—PSMB2—forebrain—Parkinson's disease	0.00508	0.0404	CbGeAlD
Carfilzomib—PSMB1—cardiovascular system—Parkinson's disease	0.0044	0.035	CbGeAlD
Carfilzomib—PSMB10—brain—Parkinson's disease	0.00434	0.0345	CbGeAlD
Carfilzomib—PSMB5—medulla oblongata—Parkinson's disease	0.0043	0.0342	CbGeAlD
Carfilzomib—PSMB2—cardiovascular system—Parkinson's disease	0.00429	0.0342	CbGeAlD
Carfilzomib—PSMB5—midbrain—Parkinson's disease	0.00393	0.0313	CbGeAlD
Carfilzomib—PSMB5—spinal cord—Parkinson's disease	0.00383	0.0305	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—Parkinson's disease	0.00376	0.0299	CbGeAlD
Carfilzomib—PSMB2—medulla oblongata—Parkinson's disease	0.00367	0.0292	CbGeAlD
Carfilzomib—PSMB1—midbrain—Parkinson's disease	0.00344	0.0273	CbGeAlD
Carfilzomib—PSMB2—midbrain—Parkinson's disease	0.00335	0.0267	CbGeAlD
Carfilzomib—PSMB1—spinal cord—Parkinson's disease	0.00335	0.0267	CbGeAlD
Carfilzomib—PSMB2—spinal cord—Parkinson's disease	0.00327	0.026	CbGeAlD
Carfilzomib—PSMB5—cerebellum—Parkinson's disease	0.00304	0.0242	CbGeAlD
Carfilzomib—PSMB1—head—Parkinson's disease	0.00298	0.0237	CbGeAlD
Carfilzomib—PSMB2—head—Parkinson's disease	0.00291	0.0231	CbGeAlD
Carfilzomib—PSMB1—nervous system—Parkinson's disease	0.00282	0.0225	CbGeAlD
Carfilzomib—PSMB8—brain—Parkinson's disease	0.0028	0.0223	CbGeAlD
Carfilzomib—PSMB2—nervous system—Parkinson's disease	0.00276	0.0219	CbGeAlD
Carfilzomib—PSMB1—central nervous system—Parkinson's disease	0.00272	0.0216	CbGeAlD
Carfilzomib—PSMB1—cerebellum—Parkinson's disease	0.00266	0.0212	CbGeAlD
Carfilzomib—PSMB2—central nervous system—Parkinson's disease	0.00265	0.0211	CbGeAlD
Carfilzomib—PSMB2—cerebellum—Parkinson's disease	0.00259	0.0206	CbGeAlD
Carfilzomib—PSMB5—brain—Parkinson's disease	0.00247	0.0197	CbGeAlD
Carfilzomib—Ritonavir—CYP2E1—Parkinson's disease	0.00223	0.266	CrCbGaD
Carfilzomib—PSMB1—brain—Parkinson's disease	0.00216	0.0172	CbGeAlD
Carfilzomib—PSMB2—brain—Parkinson's disease	0.00211	0.0168	CbGeAlD
Carfilzomib—Lopinavir—CYP2D6—Parkinson's disease	0.00195	0.233	CrCbGaD
Carfilzomib—Ritonavir—CYP2D6—Parkinson's disease	0.00164	0.195	CrCbGaD
Carfilzomib—Lopinavir—ABCB1—Parkinson's disease	0.00139	0.166	CrCbGaD
Carfilzomib—Ritonavir—ABCB1—Parkinson's disease	0.00117	0.14	CrCbGaD
Carfilzomib—ABCB1—embryo—Parkinson's disease	0.000877	0.00698	CbGeAlD
Carfilzomib—ABCB1—forebrain—Parkinson's disease	0.000775	0.00617	CbGeAlD
Carfilzomib—ABCB1—cardiovascular system—Parkinson's disease	0.000656	0.00522	CbGeAlD
Carfilzomib—ABCB1—medulla oblongata—Parkinson's disease	0.00056	0.00446	CbGeAlD
Carfilzomib—ABCB1—midbrain—Parkinson's disease	0.000512	0.00408	CbGeAlD
Carfilzomib—ABCB1—spinal cord—Parkinson's disease	0.0005	0.00398	CbGeAlD
Carfilzomib—ABCB1—head—Parkinson's disease	0.000444	0.00353	CbGeAlD
Carfilzomib—ABCB1—nervous system—Parkinson's disease	0.000421	0.00335	CbGeAlD
Carfilzomib—ABCB1—central nervous system—Parkinson's disease	0.000405	0.00323	CbGeAlD
Carfilzomib—ABCB1—cerebellum—Parkinson's disease	0.000396	0.00315	CbGeAlD
Carfilzomib—ABCB1—brain—Parkinson's disease	0.000322	0.00256	CbGeAlD
Carfilzomib—PSMB1—Immune System—ABL1—Parkinson's disease	8.47e-05	0.000301	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ABL1—Parkinson's disease	8.47e-05	0.000301	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ABL1—Parkinson's disease	8.47e-05	0.000301	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ABCB1—Parkinson's disease	8.37e-05	0.000298	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ABL1—Parkinson's disease	8.35e-05	0.000297	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ABCB1—Parkinson's disease	8.33e-05	0.000296	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—INSR—Parkinson's disease	8.18e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—INSR—Parkinson's disease	8.18e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—INSR—Parkinson's disease	8.18e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GSTM1—Parkinson's disease	8.13e-05	0.000289	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP2E1—Parkinson's disease	8.13e-05	0.000289	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP2E1—Parkinson's disease	8.13e-05	0.000289	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP2E1—Parkinson's disease	8.13e-05	0.000289	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GSTM1—Parkinson's disease	8.09e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—INSR—Parkinson's disease	8.07e-05	0.000287	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NQO1—Parkinson's disease	8.04e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NQO1—Parkinson's disease	8.04e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NQO1—Parkinson's disease	8.04e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP2E1—Parkinson's disease	8.01e-05	0.000285	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—APOE—Parkinson's disease	7.98e-05	0.000284	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HGF—Parkinson's disease	7.97e-05	0.000283	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HGF—Parkinson's disease	7.97e-05	0.000283	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HGF—Parkinson's disease	7.97e-05	0.000283	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—APOE—Parkinson's disease	7.95e-05	0.000283	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NQO1—Parkinson's disease	7.92e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—TH—Parkinson's disease	7.92e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—TH—Parkinson's disease	7.92e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—TH—Parkinson's disease	7.92e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HGF—Parkinson's disease	7.85e-05	0.000279	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—TH—Parkinson's disease	7.81e-05	0.000278	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GPX1—Parkinson's disease	7.78e-05	0.000277	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GPX1—Parkinson's disease	7.75e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGB—Parkinson's disease	7.73e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGB—Parkinson's disease	7.73e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGB—Parkinson's disease	7.73e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR1A—Parkinson's disease	7.69e-05	0.000274	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR1A—Parkinson's disease	7.69e-05	0.000274	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR1A—Parkinson's disease	7.69e-05	0.000274	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGB—Parkinson's disease	7.62e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYCS—Parkinson's disease	7.6e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYCS—Parkinson's disease	7.6e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYCS—Parkinson's disease	7.6e-05	0.00027	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	7.59e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR1A—Parkinson's disease	7.58e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TAC1—Parkinson's disease	7.58e-05	0.000269	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TAC1—Parkinson's disease	7.58e-05	0.000269	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TAC1—Parkinson's disease	7.58e-05	0.000269	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—Parkinson's disease	7.51e-05	0.000267	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ND3—Parkinson's disease	7.51e-05	0.000267	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MCCC1—Parkinson's disease	7.51e-05	0.000267	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYCS—Parkinson's disease	7.5e-05	0.000267	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TAC1—Parkinson's disease	7.47e-05	0.000266	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—DRD1—Parkinson's disease	7.43e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—DRD1—Parkinson's disease	7.43e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—DRD1—Parkinson's disease	7.43e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL6—Parkinson's disease	7.38e-05	0.000263	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—DRD1—Parkinson's disease	7.32e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—DRD3—Parkinson's disease	7.2e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—DRD3—Parkinson's disease	7.2e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—DRD3—Parkinson's disease	7.2e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF2—Parkinson's disease	7.2e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—MTHFR—Parkinson's disease	7.18e-05	0.000255	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF2—Parkinson's disease	7.16e-05	0.000255	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—MTHFR—Parkinson's disease	7.15e-05	0.000254	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—DRD3—Parkinson's disease	7.09e-05	0.000252	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TALDO1—Parkinson's disease	7.06e-05	0.000251	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—OMD—Parkinson's disease	7.06e-05	0.000251	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	6.98e-05	0.000248	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF1R—Parkinson's disease	6.96e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF1R—Parkinson's disease	6.92e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EDN1—Parkinson's disease	6.87e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EDN1—Parkinson's disease	6.84e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—INS—Parkinson's disease	6.82e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—INS—Parkinson's disease	6.79e-05	0.000241	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—COMT—Parkinson's disease	6.73e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—COMT—Parkinson's disease	6.73e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—COMT—Parkinson's disease	6.73e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ADRBK1—Parkinson's disease	6.72e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ADRBK1—Parkinson's disease	6.72e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ADRBK1—Parkinson's disease	6.72e-05	0.000239	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTP1—Parkinson's disease	6.7e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTP1—Parkinson's disease	6.7e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTP1—Parkinson's disease	6.7e-05	0.000238	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NDUFB11—Parkinson's disease	6.7e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MAOA—Parkinson's disease	6.69e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MAOA—Parkinson's disease	6.69e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MAOA—Parkinson's disease	6.69e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—APOE—Parkinson's disease	6.69e-05	0.000238	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—APOE—Parkinson's disease	6.65e-05	0.000237	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—COMT—Parkinson's disease	6.64e-05	0.000236	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ADRBK1—Parkinson's disease	6.62e-05	0.000236	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—HMOX1—Parkinson's disease	6.61e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—HMOX1—Parkinson's disease	6.61e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—HMOX1—Parkinson's disease	6.61e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTP1—Parkinson's disease	6.61e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MAOA—Parkinson's disease	6.59e-05	0.000234	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—HMOX1—Parkinson's disease	6.52e-05	0.000232	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—DRD2—Parkinson's disease	6.51e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—DRD2—Parkinson's disease	6.51e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR7—Parkinson's disease	6.51e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR7—Parkinson's disease	6.51e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR7—Parkinson's disease	6.51e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—DRD2—Parkinson's disease	6.51e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MTHFR—Parkinson's disease	6.5e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MTHFR—Parkinson's disease	6.5e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MTHFR—Parkinson's disease	6.5e-05	0.000231	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—DRD2—Parkinson's disease	6.42e-05	0.000228	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR7—Parkinson's disease	6.42e-05	0.000228	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MTHFR—Parkinson's disease	6.41e-05	0.000228	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCH1—Parkinson's disease	6.39e-05	0.000227	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ABCB1—Parkinson's disease	6.34e-05	0.000226	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ABCB1—Parkinson's disease	6.34e-05	0.000226	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ABCB1—Parkinson's disease	6.34e-05	0.000226	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NGF—Parkinson's disease	6.32e-05	0.000225	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NGF—Parkinson's disease	6.29e-05	0.000224	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ABCB1—Parkinson's disease	6.25e-05	0.000222	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTM1—Parkinson's disease	6.16e-05	0.000219	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTM1—Parkinson's disease	6.16e-05	0.000219	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTM1—Parkinson's disease	6.16e-05	0.000219	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTM1—Parkinson's disease	6.07e-05	0.000216	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APOE—Parkinson's disease	6.05e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APOE—Parkinson's disease	6.05e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APOE—Parkinson's disease	6.05e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HTR2A—Parkinson's disease	6.01e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HTR2A—Parkinson's disease	5.99e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APOE—Parkinson's disease	5.97e-05	0.000212	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GPX1—Parkinson's disease	5.9e-05	0.00021	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GPX1—Parkinson's disease	5.9e-05	0.00021	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GPX1—Parkinson's disease	5.9e-05	0.00021	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GPX1—Parkinson's disease	5.81e-05	0.000207	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—INS—Parkinson's disease	5.71e-05	0.000203	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DBH—Parkinson's disease	5.69e-05	0.000202	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—FBP1—Parkinson's disease	5.69e-05	0.000202	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GBA—Parkinson's disease	5.69e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—INS—Parkinson's disease	5.68e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APOE—Parkinson's disease	5.59e-05	0.000199	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APOE—Parkinson's disease	5.56e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL1B—Parkinson's disease	5.51e-05	0.000196	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—Parkinson's disease	5.49e-05	0.000195	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF2—Parkinson's disease	5.45e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF2—Parkinson's disease	5.45e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF2—Parkinson's disease	5.45e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTHFR—Parkinson's disease	5.44e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTHFR—Parkinson's disease	5.44e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTHFR—Parkinson's disease	5.44e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF2—Parkinson's disease	5.38e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTHFR—Parkinson's disease	5.37e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF1R—Parkinson's disease	5.27e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF1R—Parkinson's disease	5.27e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF1R—Parkinson's disease	5.27e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EDN1—Parkinson's disease	5.21e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EDN1—Parkinson's disease	5.21e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EDN1—Parkinson's disease	5.21e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1R—Parkinson's disease	5.2e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—INS—Parkinson's disease	5.17e-05	0.000184	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—INS—Parkinson's disease	5.17e-05	0.000184	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—INS—Parkinson's disease	5.17e-05	0.000184	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EDN1—Parkinson's disease	5.14e-05	0.000183	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.1e-05	0.000181	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—INS—Parkinson's disease	5.1e-05	0.000181	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOE—Parkinson's disease	5.07e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOE—Parkinson's disease	5.07e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOE—Parkinson's disease	5.07e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—MAPK8—Parkinson's disease	5.06e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MAPK8—Parkinson's disease	5.03e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOE—Parkinson's disease	5e-05	0.000178	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.97e-05	0.000177	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NGF—Parkinson's disease	4.79e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NGF—Parkinson's disease	4.79e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NGF—Parkinson's disease	4.79e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—INS—Parkinson's disease	4.78e-05	0.00017	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.78e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—INS—Parkinson's disease	4.75e-05	0.000169	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NGF—Parkinson's disease	4.72e-05	0.000168	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.69e-05	0.000167	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR2A—Parkinson's disease	4.56e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR2A—Parkinson's disease	4.56e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR2A—Parkinson's disease	4.56e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR2A—Parkinson's disease	4.49e-05	0.00016	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—INS—Parkinson's disease	4.33e-05	0.000154	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—INS—Parkinson's disease	4.33e-05	0.000154	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—INS—Parkinson's disease	4.33e-05	0.000154	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—INS—Parkinson's disease	4.27e-05	0.000152	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOE—Parkinson's disease	4.24e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOE—Parkinson's disease	4.24e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOE—Parkinson's disease	4.24e-05	0.000151	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DDC—Parkinson's disease	4.18e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—Parkinson's disease	4.18e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—Parkinson's disease	4.18e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—Parkinson's disease	4.18e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOE—Parkinson's disease	4.18e-05	0.000149	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.15e-05	0.000148	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—Parkinson's disease	4.12e-05	0.000146	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.95e-05	0.00014	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MAPK8—Parkinson's disease	3.83e-05	0.000136	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MAPK8—Parkinson's disease	3.83e-05	0.000136	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MAPK8—Parkinson's disease	3.83e-05	0.000136	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MAPK8—Parkinson's disease	3.78e-05	0.000134	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.71e-05	0.000132	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—INS—Parkinson's disease	3.62e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—INS—Parkinson's disease	3.62e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—INS—Parkinson's disease	3.62e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—INS—Parkinson's disease	3.57e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CASP3—Parkinson's disease	3.56e-05	0.000126	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.55e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CASP3—Parkinson's disease	3.54e-05	0.000126	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOB—Parkinson's disease	3.52e-05	0.000125	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MAPK8—Parkinson's disease	3.27e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MAPK8—Parkinson's disease	3.25e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—Parkinson's disease	3.23e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—Parkinson's disease	3.21e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—Parkinson's disease	2.98e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—Parkinson's disease	2.97e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CASP3—Parkinson's disease	2.7e-05	9.58e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CASP3—Parkinson's disease	2.7e-05	9.58e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CASP3—Parkinson's disease	2.7e-05	9.58e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CASP3—Parkinson's disease	2.66e-05	9.45e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.61e-05	9.29e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CTGF—Parkinson's disease	2.57e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MAPK8—Parkinson's disease	2.48e-05	8.81e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MAPK8—Parkinson's disease	2.48e-05	8.81e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MAPK8—Parkinson's disease	2.48e-05	8.81e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—Parkinson's disease	2.45e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—Parkinson's disease	2.45e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—Parkinson's disease	2.45e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MAPK8—Parkinson's disease	2.44e-05	8.68e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—Parkinson's disease	2.41e-05	8.58e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.39e-05	8.5e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NQO1—Parkinson's disease	2.36e-05	8.41e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TH—Parkinson's disease	2.33e-05	8.28e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—Parkinson's disease	2.26e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—Parkinson's disease	2.26e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—Parkinson's disease	2.26e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYCS—Parkinson's disease	2.24e-05	7.95e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—Parkinson's disease	2.23e-05	7.92e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—Parkinson's disease	2.09e-05	7.42e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—Parkinson's disease	2.08e-05	7.39e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—COMT—Parkinson's disease	1.98e-05	7.04e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.97e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOA—Parkinson's disease	1.97e-05	6.99e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.94e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.81e-05	6.44e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX1—Parkinson's disease	1.74e-05	6.17e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.6e-05	5.69e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—Parkinson's disease	1.58e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—Parkinson's disease	1.58e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—Parkinson's disease	1.58e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—Parkinson's disease	1.56e-05	5.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—Parkinson's disease	1.49e-05	5.3e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—INS—Parkinson's disease	1.27e-05	4.53e-05	CbGpPWpGaD
